News | Magnetic Resonance Imaging (MRI) | July 16, 2024

The evolution of permanent magnet open sided MRI delivers an ideal patient experience, excellent economics, and technologies to promote workflow and ease of use

The evolution of permanent magnet open sided MRI delivers an ideal patient experience, excellent economics, and technologies to promote workflow and ease of use

July 16, 2024 — Fujifilm Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging solutions, announces the U.S. launch of APERTO Lucent, a powerful open 0.4T MRI system. Relying on renowned Fujifilm permanent magnet technology, the new MRI system boasts a unique single-pillar design. The wide, laterally moving table complements the system’s open architecture to offer a comfortable patient experience.

Beyond its patient comfort advantages, the new MRI system addresses today’s capability and quality needs. RADAR motion compensating pulse sequence technology enables reduced need for rescans and minimizing artifact impact on workflow. RADAR sequences can be applied, from head to extremities, including shoulder and cervical spine, where patient motion can particularly challenge the MRI exam.

CHESS type RF Fat saturation complements STIR and Dixon type FatSep sequences, offering a comprehensive fat suppression capability. APERTO Lucent features eight channels of active patient shimming, designed to provide highest possible field uniformity in support of fat suppression and enhanced image quality.

Spatial resolution and high signal-to-noise ratio (SNR) are promoted by sensitive solenoid technology RF receiver coils and IP-Recon, Fujifilm’s iterative reconstruction algorithm. IPRecon mitigates image noise using a wavelet transform approach, which helps to provide high quality images under demanding resolution requirements.

“APERTO Lucent is a perfect solution for providers looking for a space-saving, cost-effective system that enhances the MRI patient experience,” said Shawn Etheridge, Executive Director, Modality Solutions Marketing, FUJIFILM Healthcare Americas Corporation. “With permanent magnet open MRI technology, there is little need for additional equipment and infrastructure to maintain the magnetic field, keeping installation and operating costs low for our customers and providing a stronger return on investment.”

For more information: www.healthcaresolutions-us.fujifilm.com


Related Content

News | Endoscopes

Oct. 22, 2025 — Fujifilm Healthcare Americas Corp. has launched its advanced endoscopy platform, the ELUXEO 8000 ...

Time October 23, 2025
arrow
News | X-Ray

Oct. 22, 2025 — Imaging technology company Adaptix has begun live imaging trials as part of a research program at the ...

Time October 22, 2025
arrow
News | Contrast Media

Oct. 21, 2025 — Subtle Medical, Inc., a provider of AI-powered medical imaging solutions, has announced positive ...

Time October 21, 2025
arrow
News | Radiology Imaging | UC San Diego Health

Oct. 16, 2025 — A strategic collaboration between UC San Diego Health and GE HealthCare will focus on bringing advanced ...

Time October 20, 2025
arrow
News | Artificial Intelligence

Oct. 20, 2025 — Viz.ai has launched of Viz Assist, a suite of autonomous AI agents that significantly enhance how care ...

Time October 20, 2025
arrow
News | Point-of-Care Ultrasound (POCUS)

Oct. 15, 2025 — GE HealthCare has announced the latest advancement in its Venue family of point-of-care ultrasound ...

Time October 16, 2025
arrow
News | RSNA 2025

Oct. 7, 2025 — RSNA Ventures, a mission-aligned subsidiary of Radiological Society of North America (RSNA), has ...

Time October 08, 2025
arrow
News | RSNA 2025

Oct. 7, 2025 – Clairity Inc., a leader in AI-based breast cancer risk prediction, will make five scientific ...

Time October 07, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

September 24, 2025—According to the American Journal of Roentgenology (AJR), MRI can reliably identify lateral meniscal ...

Time October 03, 2025
arrow
News | Radiopharmaceuticals and Tracers

Oct. 01, 2025 – Nuclidium AG, a clinical-stage radiopharmaceutical company developing a proprietary copper-based ...

Time October 02, 2025
arrow
Subscribe Now